Cision PR Newswire

Accident Accident Air Pollution All News Annoucement Argriculture Art ASEAN Book

Kazia Therapeutics Announces First Patient Dosed in PNOC035 Clinical Study Evaluating Paxalisib for Recurrent Pediatric AT/RT Brain Cancer

Multicenter study to evaluate paxalisib plus gemcitabine for children and young adults with recurrent or progressive AT/RT, where no approved therapies currently exist SYDNEY, Sept....

Harbour BioMed Partner, Solstice Oncology, announces $225 Million Series A Financing to Advance Porustobart, a Neoadjuvant Immuno-Oncology Therapy

Cision PR Newswire

Reveillon Creations Builds Commercial Infrastructure for Malaysian Talent into China’s Creator Economy

Douyin licensing partnership with 3Z LIVE creates a cross-border route into...

Cision PR Newswire

OceanaGold Submits Permit Application and Provides Technical and Exploration Update Supporting Mine Life Extension at Macraes

VANCOUVER, BC, Sept. 9, 2026 /PRNewswire/ -- OceanaGold Corporation (TSX: OGC, NYSE: OGC) ("OceanaGold"...

Cision PR Newswire

SK keyfoundry Expands Collaboration with Elmos on 130nm Technology and Signs Long-Term Wafer Supply Agreement

Cision PR Newswire

The VIP Advantage: Bybit Partners with SoSoValue to Issue VIP-Exclusive Daily Industry Report

DUBAI,...

China Telecom and HKUST Forge Strategic Partnership to Drive AI and Quantum Innovation

HONG KONG, April 9, 2025 /PRNewswire/ -- China Telecom Group Co., Ltd. (hereinafter referred to as "China Telecom") and The Hong Kong University of...

The next-gen MINI John Cooper Works family arrives at the all-new MINI Wan Chai Showroom in Hong Kong

All-Electric...

MEXC and BNB Chain Strengthen Ties to Empower Token Listings & Marketing

VICTORIA,...

MEXC Launches Babylon (BABY) Exclusive BTC Fixed Saving Event with up to 99% APR

VICTORIA,...

Acer Reports March Revenues at NT$29.28 Billion, Up 71.5% Month-on-Month and 6.5% Year-on-Year

TAIPEI,...

1...3,6943,6953,696...4,345 Page 3,695 of 4,345

Cision PR Newswire

Kazia Therapeutics Announces First Patient Dosed in PNOC035 Clinical Study Evaluating Paxalisib for Recurrent Pediatric AT/RT Brain Cancer

Harbour BioMed Partner, Solstice Oncology, announces $225 Million Series A Financing to Advance Porustobart, a Neoadjuvant Immuno-Oncology Therapy

Reveillon Creations Builds Commercial Infrastructure for Malaysian Talent into China’s Creator Economy

OceanaGold Submits Permit Application and Provides Technical and Exploration Update Supporting Mine Life Extension at Macraes

SK keyfoundry Expands Collaboration with Elmos on 130nm Technology and Signs Long-Term Wafer Supply Agreement

ABOUT US

FOLLOW US